Cargando…

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma

Kaposi’s sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Croci, Diego O., Salatino, Mariana, Rubinstein, Natalia, Cerliani, Juan P., Cavallin, Lucas E., Leung, Howard J., Ouyang, Jing, Ilarregui, Juan M., Toscano, Marta A., Domaica, Carolina I., Croci, María C., Shipp, Margaret A., Mesri, Enrique A., Albini, Adriana, Rabinovich, Gabriel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478924/ https://www.ncbi.nlm.nih.gov/pubmed/23027923 http://dx.doi.org/10.1084/jem.20111665

Ejemplares similares

Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
por: Croci, Diego O, et al.
Publicado: (2014)

The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine
por: Muglia, C, et al.
Publicado: (2011)

Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors
por: Etulain, Julia, et al.
Publicado: (2014)

KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi’s sarcoma
por: Medina, María Victoria, et al.
Publicado: (2020)

"Time sweet time": circadian characterization of galectin-1 null mice
por: Casiraghi, Leandro P, et al.
Publicado: (2010)

Molecular and Cellular Mechanisms of KSHV Oncogenesis of Kaposi's Sarcoma Associated with HIV/AIDS
por: Cavallin, Lucas E., et al.
Publicado: (2014)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells
por: Benatar, Alejandro F., et al.
Publicado: (2015)

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma
por: Cavallin, Lucas E, et al.
Publicado: (2010)

Galectin-1 is essential for efficient liver regeneration following hepatectomy
por: Potikha, Tamara, et al.
Publicado: (2016)

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
por: Cagnoni, Alejandro J., et al.
Publicado: (2016)

Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis
por: Alcendor, DJ, et al.
Publicado: (2009)

Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
por: Pinto, Nicolás A., et al.
Publicado: (2023)

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
por: Girotti, María Romina, et al.
Publicado: (2019)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF
por: Ridano, Magali E., et al.
Publicado: (2017)

KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis
por: Cavallin, Lucas E., et al.
Publicado: (2018)

Inflammatory angiogenesis as a target for prevention and therapy: Kaposi's sarcoma and HIV tat as models
por: Albini, Adriana, et al.
Publicado: (2006)

An Automated Approach to Assess Relative Galectin-Glycan Affinity Following Glycan Microarray Analysis
por: Ho, Alex D., et al.
Publicado: (2022)

Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
por: Bannoud, Nadia, et al.
Publicado: (2023)

Chemokines modulate glycan binding and the immunoregulatory activity of galectins
por: Sanjurjo, Lucía, et al.
Publicado: (2021)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Viral G Protein–Coupled Receptor and Kaposi's Sarcoma: A Model of Paracrine Neoplasia?
por: Cesarman, Ethel, et al.
Publicado: (2000)

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
por: Sundblad, Victoria, et al.
Publicado: (2021)

Glycan Dependence of Galectin-3 Self-Association Properties
por: Halimi, Hubert, et al.
Publicado: (2014)

Galectin-Glycan Interactions as Regulators of B Cell Immunity
por: Giovannone, Nicholas, et al.
Publicado: (2018)

Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection
por: Pinho, Salomé S., et al.
Publicado: (2023)

The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin–glycan interactions at the cell surface
por: Miller, Michelle C., et al.
Publicado: (2009)

KSHV regulation of fibulins in Kaposi’s sarcoma: implications for tumorigenesis
por: Alcendor, Donald, et al.
Publicado: (2010)

Introducing affinity and selectivity into galectin-targeting nanoparticles with fluorinated glycan ligands
por: Richards, Sarah-Jane, et al.
Publicado: (2020)

Tumor Necrosis Factor Receptor-1 (p55) Deficiency Attenuates Tumor Growth and Intratumoral Angiogenesis and Stimulates CD8(+) T Cell Function in Melanoma
por: Rodriguez, Yamila I., et al.
Publicado: (2020)

Microbe–Host Interactions are Positively and Negatively Regulated by Galectin–Glycan Interactions
por: Baum, Linda G., et al.
Publicado: (2014)

The role of galectin-3 in the tumorigenesis and progression of pituitary tumors
por: Diao, Bo, et al.
Publicado: (2018)

Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery
por: Clemente, Tiago, et al.
Publicado: (2017)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Galectins in Endothelial Cell Biology and Angiogenesis: The Basics
por: Thijssen, Victor L.
Publicado: (2021)

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
por: Mendez-Huergo, Santiago P., et al.
Publicado: (2019)

A unique role for galectin-9 in angiogenesis and inflammatory arthritis
por: O’Brien, Martin J., et al.
Publicado: (2018)

Productively Infected Murine Kaposi's Sarcoma-Like Tumors Define New Animal Models for Studying and Targeting KSHV Oncogenesis and Replication
por: Ashlock, Brittany M., et al.
Publicado: (2014)

Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans
por: Giovannone, N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rlftmde42bg7onqpfcpkjcpsbd